Working… Menu

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02663271
Recruitment Status : Terminated (stagnant enrollment)
First Posted : January 26, 2016
Last Update Posted : August 11, 2021
NovoCure Ltd.
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 11, 2021
Actual Study Completion Date : June 11, 2021